FR2270882B1 - - Google Patents

Info

Publication number
FR2270882B1
FR2270882B1 FR7514692A FR7514692A FR2270882B1 FR 2270882 B1 FR2270882 B1 FR 2270882B1 FR 7514692 A FR7514692 A FR 7514692A FR 7514692 A FR7514692 A FR 7514692A FR 2270882 B1 FR2270882 B1 FR 2270882B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7514692A
Other versions
FR2270882A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of FR2270882A1 publication Critical patent/FR2270882A1/fr
Application granted granted Critical
Publication of FR2270882B1 publication Critical patent/FR2270882B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7514692A 1974-05-15 1975-05-12 Expired FR2270882B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/470,233 US3931160A (en) 1974-05-15 1974-05-15 α-Amino-α-(acylamidophenyl)acetamidocephalosporins

Publications (2)

Publication Number Publication Date
FR2270882A1 FR2270882A1 (fr) 1975-12-12
FR2270882B1 true FR2270882B1 (fr) 1978-08-04

Family

ID=23866778

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7514692A Expired FR2270882B1 (fr) 1974-05-15 1975-05-12

Country Status (9)

Country Link
US (1) US3931160A (fr)
JP (1) JPS50154287A (fr)
BE (1) BE829025A (fr)
CH (1) CH610328A5 (fr)
DE (1) DE2521063A1 (fr)
FR (1) FR2270882B1 (fr)
GB (1) GB1457484A (fr)
LU (1) LU72459A1 (fr)
NL (1) NL7505734A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
CA1074784A (fr) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDOCEPHALOSPORINES
US4160087A (en) * 1974-09-06 1979-07-03 Sumitomo Chemical Company, Limited N-acylamino-α-arylacetamido cephalosporins
US4118491A (en) * 1976-03-11 1978-10-03 Smithkline Corporation 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4171362A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins antibacterial compositions containing them and methods of treating bacterial infections with them
US4171368A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Acylamino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them
US4171433A (en) * 1975-10-30 1979-10-16 Smithkline Corporation 7-Amino-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporin intermediates for preparing 7-acylamino cephalosporins
US4082912A (en) * 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
US4112228A (en) * 1976-07-13 1978-09-05 Bristol-Myers Company 7-(D-α-Hydroxy-2-arylacetamido)-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo-[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acids and derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3464985A (en) * 1967-08-18 1969-09-02 Bristol Myers Co 7 - (d - alpha - amino - (acetamidophenylacetamido))-cephalosporanic acids and derivatives thereof
US3813388A (en) * 1972-01-31 1974-05-28 L Crast 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
US3776906A (en) * 1972-03-16 1973-12-04 Bristol Myers Co 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-thienyl-acetamido))-3-(1,2,5-thiadiazol-3-yl)carbonylthiomethyl-3-cephem-4-carboxylic acids
US3840535A (en) * 1972-08-23 1974-10-08 Bristol Myers Co Dimethanesulfonates of certain 7-(o-aminomethylphenylacetamido)-3-((heterocyclylthio)methyl)-ceph-3-em-4-carboxylic acids

Also Published As

Publication number Publication date
JPS50154287A (fr) 1975-12-12
CH610328A5 (fr) 1979-04-12
GB1457484A (en) 1976-12-01
NL7505734A (nl) 1975-11-18
FR2270882A1 (fr) 1975-12-12
BE829025A (fr) 1975-11-13
US3931160A (en) 1976-01-06
DE2521063A1 (de) 1975-11-27
LU72459A1 (fr) 1975-08-28

Similar Documents

Publication Publication Date Title
FR2256962A1 (fr)
CH578204B5 (fr)
CH567395A5 (fr)
AU481101A (fr)
AU481663A (fr)
BG19668A1 (fr)
BG19764A1 (fr)
BG20660A1 (fr)
BG20668A2 (fr)
BG20937A1 (fr)
BG20947A1 (fr)
BG20994A1 (fr)
BG21067A1 (fr)
BG21312A1 (fr)
BG21341A1 (fr)
BG21690A2 (fr)
BG21760A1 (fr)
BG22061A3 (fr)
CH578712A5 (fr)
BG22667A1 (fr)
BG26365A3 (fr)
BG26517A4 (fr)
CH1378974A4 (fr)
CH1666774A4 (fr)
CH532175A4 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse